{
    "organizations": [],
    "uuid": "dc4cd8b75007399fa1caf2ccadbde96b2ce34431",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-novartis-new-ceo-sandoz-remains-pi/brief-novartis-new-ceo-sandoz-remains-pillar-despite-u-s-business-review-idUSZ8N15A01L",
    "ord_in_thread": 0,
    "title": "BRIEF-Novartis new CEO: Sandoz remains pillar, despite U.S. business review",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 24 (Reuters) - Novartis:\n* INCOMING CEO SAYS OPTIMISTIC ABOUT SOLID SALES GROWTH OVER NEXT FIVE YEARS\n* INCOMING CEO SAYS PRICE PRESSURE ON SANDOZ IN UNITED STATES CAUSING COMPANY TO LOOK AGGRESSIVELY AT RESHAPING U.S. GENERIC PORTFOLIO\n* INCOMING CEO SAYS HAS NOT YET MADE ANY DECISIONS ON SANDOZ‘S ORAL SOLIDS GENERICS BUSINESS IN U.S., UNDER REVIEW\n* INCOMING CEO SAYS INITIALLY SAW “BUMPS” IN KYMRIAH ROLLOUT IN PEDIATRIC ALL, NOW SEES ACCELERATION\n* INCOMING CEO SAYS NO CHANGE TO NOVARTIS‘S POSITION ON GSK JOINT VENTURE OR ROCHE STAKE\n* INCOMING CEO SAYS ALMOST EVERY PATIENT IN KYMRIAH LAUNCH HAS UNIQUE INSURANCE REIMBURSEMENT PROFILE, STILL CONSIDERING PRICING MODEL FOR ADDITIONAL INDICATIONS\n* INCOMING CEO SAYS NO ACTION ON ALCON SPINOFF BEFORE FIRST HALF 2019\n* INCOMING CEO SAYS ON TRACK TO DELIVER CORE MARGIN EXPANSION IN 2018\n* INCOMING CEO SAYS WE CONTINUE TO HOLD TO OUR STRATEGY OF BOLT-ON ACQUISITIONS TO SUPPORT CORE AREAS INCLUDING ONCOLOGY\n* GENERAL COUNSEL SAYS “LOOKING AT ALL OPPORTUNITIES” WITH REGARDS TO RESOLVING U.S. DOJ LEGAL ACTION TARGETING SPEAKERS PROGRAM\n* INCOMING CEO SAYS SANDOZ REMAINS PILLAR, DESPITE REVIEW OF U.S. GENERICS BUSINESS AMID PRICE PRESSURE Source text for Eikon: Further company coverage: (Reporting by John Miller)\n ",
    "published": "2018-01-24T19:03:00.000+02:00",
    "crawled": "2018-01-25T12:59:21.023+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "novartis",
        "incoming",
        "ceo",
        "say",
        "optimistic",
        "solid",
        "sale",
        "growth",
        "next",
        "five",
        "year",
        "incoming",
        "ceo",
        "say",
        "price",
        "pressure",
        "sandoz",
        "united",
        "state",
        "causing",
        "company",
        "look",
        "aggressively",
        "reshaping",
        "generic",
        "portfolio",
        "incoming",
        "ceo",
        "say",
        "yet",
        "made",
        "decision",
        "sandoz",
        "oral",
        "solid",
        "generic",
        "business",
        "review",
        "incoming",
        "ceo",
        "say",
        "initially",
        "saw",
        "bump",
        "kymriah",
        "rollout",
        "pediatric",
        "see",
        "acceleration",
        "incoming",
        "ceo",
        "say",
        "change",
        "novartis",
        "position",
        "gsk",
        "joint",
        "venture",
        "roche",
        "stake",
        "incoming",
        "ceo",
        "say",
        "almost",
        "every",
        "patient",
        "kymriah",
        "launch",
        "unique",
        "insurance",
        "reimbursement",
        "profile",
        "still",
        "considering",
        "pricing",
        "model",
        "additional",
        "indication",
        "incoming",
        "ceo",
        "say",
        "action",
        "alcon",
        "spinoff",
        "first",
        "half",
        "incoming",
        "ceo",
        "say",
        "track",
        "deliver",
        "core",
        "margin",
        "expansion",
        "incoming",
        "ceo",
        "say",
        "continue",
        "hold",
        "strategy",
        "acquisition",
        "support",
        "core",
        "area",
        "including",
        "oncology",
        "general",
        "counsel",
        "say",
        "looking",
        "opportunity",
        "regard",
        "resolving",
        "doj",
        "legal",
        "action",
        "targeting",
        "speaker",
        "program",
        "incoming",
        "ceo",
        "say",
        "sandoz",
        "remains",
        "pillar",
        "despite",
        "review",
        "generic",
        "business",
        "amid",
        "price",
        "pressure",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "reporting",
        "john",
        "miller"
    ]
}